discuss NordICC with the trial PI
Power calc specified 50% non-adherence
ADR is on par with US studies from the time
Colo quality good
Perf rate lower than US!
How does he counsel individuals & governments
What he thinks of USPSTF

5.23 - ID Ethicist joins me for a 6th discussion of COVID19 policy

Dr Prasad currently serves as the Director of the Center for Biologics Evaluation and Resesarch (CBER) at the US FDA. The audio on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service.

A podcast on medicine, oncology, & health policy. 
Host: Vinay Prasad, MD MPH from University of California San Francisco.
Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com